Each year we provide a range of research funding opportunities. Find out more about our grants making process and current funding available.
Research awards 2021/2022
An announcement about our research awards for 2021/22 will be made here in September 2021.
Allied Healthcare Professionals Award 2020
Dr Jonathan Denniss from the University of Bradford has been awarded £48,000 for his project ‘Melanopsin-Based Intrinsically Photosensitive Retinal Ganglion Cell Function: A Novel Objective Test for Glaucoma’. This is a new and easy way of testing for glaucoma using a combination of coloured light to record pupil reaction. There has been a delayed start due to the escalation of the pandemic and new variant, although the team are hoping to get started early summer 2021.
Closed – this is currently out for peer review and an announcement will be made in the next few weeks.
Closed – this is currently in progress and an announcement will be made in May 2021.
COVID-19 is putting an enormous strain on front line healthcare workers across the UK, so we have unfortunately had to delay the awards process for Glaucoma UK research grants to allow our NHS colleagues to focus on those needing their help. We are aware that researchers will also struggle to recruit patients to new trials under the current circumstances, so a delay makes practical sense for our researchers too.
Please rest assured that research into the cause and treatment of glaucoma remains a top priority for Glaucoma UK, and we will bring you news of the awards as soon as the grants panels are able to meet again.
Budgets are agreed annually in July and are announced here on our website, on social media and through partner organisations. The annual grants budget is typically between £200,000 and £400,000.
Grants are awarded in open competition by an awards panel chaired by trustee Nick Strouthidis MBBS MD PhD FRCS FRCOphth FRANZCO. Other panel members are drawn from our Clinical Advisory Panel.
Grants will be awarded on the basis of:
• scientific content
• likelihood of a conclusive outcome of the proposed study
• likely impact of the research on patient care or appropriate scientific advance or understanding of glaucoma
• location in a suitable institution
• value for money
• ethical considerations
• whether they address our current strategic research priorities
All awards are subject to a peer review process.
For more details see our FAQs
National Institute for Health Research support
Glaucoma UK is a National Institute for Health Research (NIHR) non-commercial partner. This means the studies we fund may be eligible to access the Study Support Service provided by the NIHR Clinical Research Network. See our research funding FAQs for further details.